In 2003, the MOPH published a first National Essential ... · هماع تحص تراو Ministry of...
Transcript of In 2003, the MOPH published a first National Essential ... · هماع تحص تراو Ministry of...
زارت صحت عامهو
Ministry of Public Health یطب معالجو یاست عمومیر
General Directorate of Curative Medicine
مرکز یاست شفاخانه هایر
Directorate of Central Hospitals
نید معلولمجد یایاست شفاخانه احیر
Rehabilitation of Disabled Hospital
یومعالجو یته دوائیکم
Drug & Therapeutics Committee
یلست فورمولر
Formulary List
June 2015
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 3 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
ACRONYMS
ATC Anatomical Therapeutic Chemical
mcg Micro gram
g Gram
IU International Units
L Liter
mg Milligram
ml Milliliter
MU Million units
IV Intravenous
kg Kilo gram
cm Centimeter
m2 Square meter
Vit Vitamin
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 4 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
ANATOMO-THERAPEUTIC-CHEMICAL (ATC) CLASSIFICATION
A- ALIMENTARY TRACT AND METABOLISM
A02- DRUGS FOR ACID RELATED DISORDERS A02A- ANTACIDS
Aluminium hydroxide + Magnesium hydroxide Chewable tablet: 200 mg + 200 mg
Aluminium hydroxide +Magnesium hydroxide Oral Suspension: 225mg+200 mg in 200 ml
A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Esomeprazole Capsule: 40 mg Esomeprazole Capsule: 20 mg
Famotidine Tablet: 40 mg
Omeprazole Capsule: 20 mg
Ranitidine Tablet: 150 mg
A03- DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS A03B -BELLADONNA AND DERIVATIVES, PLAIN
Hyoscine (butylbromide, hydrobromide) Tablet: 10 mg
Hyoscine (butylbromide, hydrobromide) Injection ampoule: 20 mg/ml, in 1 ml A03F- PROPULSIVES
Domperidone Tablet: 10 mg
Metoclopramide Tablet: 10 mg
Metoclopramide Injectable solution: 5 mg/ml in 2 ml ampoule
A06- LAXATIVES
A06A—LAXATIVES
Bisacodyl Tablet: 5 mg
A07- ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE A07A- INTESTINAL ANTIINFECTIVES
Nystatin Oral topical drop: 100,000 IU
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 5 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
A07C- ELECTROLYTES WITH CARBOHYDRATES
Oral Rehydration Salts (ORS) Oral Powder: 27.9 g/L in 1 L Sachet
A10. DRUGS USED IN DIABETES A10B- BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Glibenclamide Tablet: 5 mg
Metformin Tablet: 500 mg
A11. VITAMINS A11A - MULTIVITAMINS, PLAIN
Multivitamins and other minerals Tablet
A11B—MULTIVITAMINS, PLAIN
Multivitamins Tablet
A11C- VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO
Colecalciferol (Vit D3) Injection ampoule: 600,000 IU/ml
Retinol (Vit A) Tablet: 100,000 IU
Calcium Phosphate + Vitamin D Syrup: 210 mg + 350 IU/5 ml, in 110 ml
A11G- ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS
Ascorbic Acid (Vit C) Tablet: 500 mg
A11H – OTHER PLAIN VITAMIN PREPARATION
Pyridoxine (Vitamin B6) Tablet: 25 mg
A12- MINERAL SUPPLEMENTS A12A - CALCIUM
Calcium gluconate Injectable solution: 10%, in 10 ml ampoule
B- BLOOD AND BLOOD FORMING ORGANS
B01- ANTITHROMBOTIC AGENTS B01A—ANTITHROMBOTIC AGENTS
Acetylsalicylic acid (Aspirin) (ASA) Tablet: 100 mg
Clopidogrel Tablet: 75 mg
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 6 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
B03- ANTIANEMIC PREPARATIONS B03A- IRON PREPARATIONS
Ferrous sulfate (strength in Fe equivalent) + Folic acid Tablet: 60 mg + 0.4 mg
B03B. VITAMIN B12 AND FOLIC ACID
Folic acid (Vit B9) Tablet: 5 mg
Hydroxocobalamine (Vit B12) Injectable Ampoule: 0.5 mg/ml, in 1 ml
Mecobalamine (Vit B12) Tablet: 500 mg
B05- BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS B05B- I.V. SOLUTIONS
Glucose + Sodium chloride Injectable solution: 5% + 0.9%, in 500 ml bottle
Glucose + Sodium chloride Injection solution: 5% +0.9%, in 1000 ml bottle
Sodium chloride Injectable solution: 0.9%, in 500 ml bottle
Sodium chloride Injectable solution: 0.9%, in 1000 ml bottle
Ringer lactate Injectable solution: in 500 ml bottle
Ringer lactate Injectable solution: in 1000 ml bottle
B05C- IRRIGATING SOLUTIONS
Glucose Injectable solution: 5%, in 500 ml bottle
Glucose Injectable solution: 5%, in 1000 ml bottle
Glucose Injectable solution: 10%, in 500 ml bottle
Glucose Injectable solution: 10%, in 1000 ml bottle
C- CARDIOVASCULAR SYSTEM
C02- ANTIHYPERTENSIVES C02A- ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Methyldopa Tablet: 250 mg C03- DIURETICS C03A- LOW-CEILING DIURETICS, THIAZIDES
Hydrochlorothiazide Tablet: 25 mg
Hydrochlorothiazide Tablet: 50 mg
C03C- HIGH-CEILING DIURETICS
Furosemide Tablet: 40 mg
Furosemide Tablet: 20 mg
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 7 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
C07- BETA BLOCKING AGENTS C07A- BETA BLOCKING AGENTS
Atenolol Tablet: 100 mg
Propranolol Tablet: 10 mg
C08- CALCIUM CHANNEL BLOCKING AGENTS C08c- SELECTIVE CALCIUMCHANNEL BLOCKING MAINLY WITH VASCULAR EFFECTS
Amlodipine Tablet: 5 mg
Nifedipine Tablet: 10 mg
C09- AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM C09A- ACE INHIBITORS, PLAIN
Captopril Tablet: 25 mg
C10. LIPID MODIFYING AGENTS C10A. LIPID MODIFYING AGETNTS, PLAN
Atorvastatin Tablet: 20 mg
Fenofibrate Tablet: 200 mg
D- DERMATOLOGICALS
D04- ANTIPRURITICS, INCLUDING ANTIHSTAMINES, ANESTHETICS D04A—ANTIPRURITICS, INCLUDING ANTIHISTAMINES, ANESTHETICS, AND OTHERS
Lidocaine Topical cream: 2%
D06B- CHEMOTHERAPEUTICS FOR TOPICAL USE
Silver sulfadiazine Topical cream: 1% in 20 gr
D08- ANTISEPTICS AND DISINFECTANTS D08A—ANTISEPTICS AND DISINFECTANTS
Chlorhexidine digluconate Topical Solution: 5%
Hydrogen peroxide Topical Solution: 6%
Chloroxylenol Topical Solution: 4.8%
Povidone iodine Topical Solution: 10%
Chlorine Topical Solution: 0.5%
Ethanol Topical Solution: 70%
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 8 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
D11—OTHER DERMATOLOGICAL PREPARATIONS D11A—OTHER DERMATOLOGICAL PREPARATIONS
Diclofenac Topical Gel: 1%, in 20 gr
H- CORTICOSTEROIDS FOR SYSTEMIC USE
H02A- CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Betamethasone Injectable Solution: 4 mg/ml, in 1 ml
Dexamethasone Injectable Solution: 4mg/ml, in 2 ml ampoule
Dexamethasone Tablet: 0.5 mg
Hydrocortisone sodium succinate Injectable Solution: 100 mg/vial
Methylprednisolone Injectable Solution: 40 mg/ml, in 2 ml ampoule
Prednisolone Tablet: 5 mg
J- ANTIINFECTIVES FOR SYSTEMIC USE
J01- ANTIBACTERIALS FOR SYSTEMIC USE J01A- TETRACYCLINES
Doxycycline Capsule: 100 mg
J01B- AMPHENICOLS
Chloramphenicol Injectable Solution: 1g/vial
J01C- BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Amoxicillin Oral suspension: 125 mg/5 ml in 60 ml
Amoxicillin Oral suspension: 250 mg/5 ml in 60 ml
Amoxicillin Capsule: 250 mg
Amoxicillin Capsule: 500 mg
Amoxicillin + Clavulanic acid (Co-amoxiclav) Tablet: 500 mg + 125 mg
Ampicillin Injectable powder: 500 mg/vial
Ampicillin Injectable powder: 1g/vial
Ampicillin + cloxacillin Tablet: Capsule: 250 mg + 250 mg
Cloxacillin Tablet: Capsule: 250 mg
Cloxacillin Tablet: Capsule: 500 mg
Penicillin Benzyl Benzathine Injectable solution: 1.2 MU/vial
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 9 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
J01D- OTHER BETA-LACTAM ANTIBACTERIALS
Ceftriaxone Injectable powder: 500 mg/vial
Ceftriaxone Injectable powder: 1g/vial
Cefixime Tablet: 200 mg
Cefixime Tablet: 400 mg
Cefixime Oral suspension: 100 mg/5 ml in 30 ml
Cefixime Oral suspension: 200 mg/5 ml in 30 ml
J01E- SULFONAMIDES AND TRIMETHOPRIM
Sulfamethoxazole + Trimethoprim (Cotrimoxazole) Tablet: 400 mg + 80 mg
Sulfamethoxazole + Trimethoprim (Cotrimoxazole) Oral suspension: 200 mg+40 mg/5 ml in 50 ml
J01F- MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Azithromycin Capsule: 250 mg
Azithromycin Capsule: 500 mg
Clarithromycin Tablet: 250 mg
Erythromycin (stearate) Tablet: 250 mg
Erythromycin (stearate) Tablet: 500 mg
J01G- AMINOGLYCOSIDE ANTIBACTERIALS
Amikacin Injectable Solution: 250 mg/1 ml, in 2 ml
Gentamicin Injectable Solution: 40 mg/ml, in 2 ml
J01M- QUINOLONE ANTIBACTERIALS
Ciprofloxacin Tablet: 250 mg
Ciprofloxacin Tablet: 500 mg
Ciprofloxacin Tablet: 750 mg
Gatifloxacin Tablet: 200 mg
Gatifloxacin Tablet: 400 mg
Levofloxacin Tablet: 250 mg
Levofloxacin Tablet: 500 mg
Ofloxacin Tablet: 200 mg
Ofloxacin Tablet: 400 mg
Nalidixic Acid Tablet: 250 mg
Nalidixic Acid Tablet: 500 mg
J01X-OTHER ANTIBACTERIALS
Nitrofurantoin Tablet: 100 mg
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 10 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
M- MUSCULO-SKELETAL SYSTEM
M01- ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS M01A- ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Celecoxib Capsule: 100 mg
Celecoxib Capsule: 200 mg
Diclofenac (sodium or potassium) Tablet: 50 mg
Diclofenac (sodium or potassium) Tablet: 75 mg
Diclofenac Injection: 25 mg/ml, in 3 ml
Ibuprofen Tablet: 200 mg
Ibuprofen Tablet: 400 mg
Ibuprofen Syrup: 100 mg/5 ml in 60 ml
Indomethacin Tablet: 75 mg
Indomethacin Injectable solution: 37.5 mg/ml in 2 ml
Ketoprofen Tablet: 100 mg
Ketoprofen Tablet: 200 mg
Meloxicam Tablet: 7.5 mg
Meloxicam Tablet: 15 mg
Naproxen Tablet: 250 mg
Naproxen Tablet: 550 mg
Nimesulide Tablet: 100 mg
Piroxicam Capsule: 20 mg
Piroxicam Injectable solution: 10 mg/ml, in 2 ml
Piroxicam Topical Gel: 0.5%
M03—MUSCLE RELAXANTS M03B—MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Orphenadrine + Paracetamol Tablet: 35mg + 450 mg
N - NERVOUS SYSTEM
N01. ANESTHETICS N01B- ANESTHETICS, LOCAL
Lidocaine Injectable solution: 2%, in 2 ml ampoule
Adrenalin + Lidocaine Injectable solution: 0.00125% + 1%
Adrenalin + Lidocaine dental Injectable solution: 0.00125% + 2%
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 11 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
N02- ANALGESICS
N02A- OPIOIDS
Tramadol Tablet: 50 mg
N02B—OTHER ANALGESICS AND ANTIPYRETICS
Acetylsalicylic acid (Aspirin) Tablet: 500 mg
Paracetamol (Acetaminophen) Tablet: 500 mg
Paracetamol (Acetaminophen) Syrup: 120 mg/5 ml
Paracetamol (Acetaminophen) Rectal Suppository: 125 mg
N03- ANTIEPILEPTICS
N03A—ANTIEPILEPTICS
Carbamazepine Tablet: 100 mg
Magnesium sulfate Injectable solution: 500mg/ml in 10 ml ampoule
Phenobarbital Tablet: 100 mg
Phenobarbital Tablet: 15 mg
Valproic acid Tablet: 250 mg
N04- ANTI-PARKINSON MEDICINES
N04A- ANTICHOLINERGIC AGENTS
Trihexyphenidyl Tablet: 2 mg
N05- PSYCHOLEPTICS
N05B. ANXIOLYTICS
Alprazolam Tablet: 0.5 mg
Diazepam Tablet: 10 mg
Diazepam Tablet: 5 mg
Diazepam Tablet: 2 mg
N06- PSYCHOANALEPTICS
N06A- ANTIDEPRESSANTS
Amitriptyline Tablet: 25 mg
Fluoxetine Capsule: 20 mg
Imipramine Tablet: 10 mg
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 12 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
P- ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01- ANTIPROTOZOALS P01A- AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
Metronidazole Tablet: 200 mg
Metronidazole Tablet: 400 mg
Metronidazole Syrup: 200 mg/5 ml in 60 ml bottle
P01B- ANTIMALARIALS
Chloroquine (base) Tablet: 150 mg
P02- ANTHELMINTICS P02C—ANTINEMATODAL AGENTS
Albendazole Chewable tablet: 200 mg
Albendazole Chewable tablet: 400 mg
Mebendazole Tablet: 100 mg
R- RESPIRATORY SYSTEM
R01. NASAL PREPARATIONS R01A- DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL
Naphazoline Nasal drop: 0.05% in 10ml bottle
Sodium chloride Nasal drop: 0.65%, in10 ml bottle
R03- DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES R03A- ADRENERGICS, INHALANTS
Salbutamol Inhalation solution: 0.1mg/ dose, in 200 dose bottle
Beclometasone dipropionate Inhalation aerosol: 250 mcg per dose
R03C- ADRENERGICS FOR SYSTEMIC USE
Salbutamol Tablet: 2 mg
Salbutamol Tablet: 4 mg
Salbutamol Syrup: 2 mg/5 ml in 60ml bottle
R03D- OTHER SYSTEMIC MEDICINES FOR OBSTRUCTIVE AIRWAY DISEASES
Aminophylline Injectable solution: 25 mg/ml, in 10 ml
Aminophylline Tablet: 100 mg
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 13 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
R06- ANTIHISTAMINES FOR SYSTEMIC USE R06A- ANTIHISTAMINES FOR SYSTEMIC USE
Chlorphenamine maleate Tablet: 4 mg
Dimenhydrinate Tablet: 50 mg
Diphenhydramine chloride Syrup: 5 mg/ ml in 60ml
Promethazine Tablet: 25 mg
Loratadine Tablet: 10 mg
S- SENSORY ORGANS
S01- OPHTHALMOLOGICALS S01A- EYE ANTI-INFECTIVES
Chloramphenicol Ophthalmic drop 0.5% in 2.5 ml bottle
Tetracycline Ophthalmic ointment: 1% in 5g tube
Bacitracin Ophthalmic ointment: 500 IU/g, in 3.5 g tube
S01B- EYE ANTI-INFLAMMATORY
Prednisolone acetate Ophthalmic drop: 0.5%, in 5 ml bottle
Prednisolone acetate Ophthalmic drop: 1%, in 5 ml bottle
S01H- EYE LOCAL ANESTHETIC
Tetracaine Ophthalmic drop: 0.5% in15 ml bottle
SO2A – EYE ANTIINFCTIVES
Boric acid + glycerin 5% (glycerin boric) Otic liquid: 5% in 10 ml
V07- ALL OTHER NON-THERAPEUTIC PRODUCTS V07A—ALL OTHER NONTHERAPEUTIC PRODUCTS
Water for Injection Injectable solution: 10 ml ampoule
Water for Injection Injectable solution: 5 ml ampoule
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 14 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
APPENDIX A. BODY SURFACE AREA AND MEDICINE DOSAGE
______________________
Body surface area in m2 = √ {height (cm) x weight (kg)}
3600 Thus a child weighing 10 kg and 72 cm long has a body surface area of
45.00)(10x72/360
Table A1. Drug Dosage by surface area (m2) of the child
Age or weight of child Surface area ________________________________________________
Neonate (< 1 month) 0.2–0.25 m2 ________________________________________________
Young infant (1–<3 months) 0.25–0.35 m2 ________________________________________________
Child 5–9 kg 0.3–0.45 m2 ________________________________________________
Child 10–14 kg 0.45–0.6 m2 ________________________________________________
Child 15–19 kg 0.6–0.8 m2 ________________________________________________
Child 20–24 kg 0.8–0.9 m2 ________________________________________________
Child 25–29 kg 0.9–1.1 m2 ________________________________________________
Child 30–39 kg 1.1–1.3 m2 ________________________________________________
Note: Example if the recommended dose is given as 400 mg/m2 twice per day,
then a child in the weight range of 15–19 kg should receive the recommended dose of
(0.6–0.8) x 400 = 244–316 mg twice per day
Source: Hospital Care for Children, World Health Organization
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 15 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
APPENDIX B. COMPARISON OF PERCENTAGE WITH RATIO, TEMPERATURE,
WEIGHT, VOLUME, LENGTH
Length
1 meter = 100 centimeters = 1,000 millimeters 10 millimeters = 1 centimeter
Temperature Conversion
°C x 9/5 + 32 = °F
(°F − 32) x 5/9 = °C
Weight
1 gram = 1,000 milligrams
1 milligram = 1,000 micrograms
1 kilogram = 1,000 grams
1 kilogram = 2.2 pounds
1 pound = 6 ounces
Comparison of Percentage and Ratio
1:100 1:200
= 1g/100ml [10mg/ml] = 500mg/100ml [5mg/ml]
= 1%
= 0.5%
1:1,000 1:5,000
= 100mg/100ml [1mg/ml] = 20mg/100ml [200mcg/ml]
= 0.1%
= 0.02%
1:10,000 = 10mg/100ml [100mcg/ml] = 0.01%
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 16 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
1 liter 1,000 milliliters
1 quart / 32 ounces / 2 pints 500 milliliters
1 pint / 16 ounces / 2 cups 240 milliliters
1 cup / 8 ounces 30 milliliters
1 ounce 15 milliliters
1 tablespoon / 3 teaspoons 5 milliliters
15 drops 0.0667 milliliters
1 drop
Source: Simmers, Louise. Diversified Health Occupations (OR
Introduction to Health Science Technology). Delmar, Latest edition.
Volume
1,000 cubic millimeters = 1 cubic centimeter
1,000 cubic centimeters = 1 cubic decimeter
1,000 cubic decimeters = 1 cubic meter
10 deciliters = 1 liter
1 liter = 1,000 milliliters
10 centiliters = 1 deciliter
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 17 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
APPENDIX C. WEIGHT PER HEIGHT
Height Estimated Lean Body Weight
(+) or ( - ) 2.3 kg per inch over/under 5 feet tall (+) 50 kg for men or (+) 45.5 kg for women
Imperial / metric Males (kg) Females (kg)
4 ft 8 in / 142 cm 40.8 36.3
4 ft 9 in / 145 cm 43.1 38.6
4 ft 10 in / 147 cm 45.4 40.9
4 ft 11 in / 150 cm 47.7 43.2
5 ft 0 in / 152 cm 50.0 45.5
5 ft 1 in / 155 cm 52.3 47.8
5 ft 2 in / 157 cm 54.6 50.1
5 ft 3 in / 160 cm 56.9 52.4
5 ft 4 in / 163 cm 59.2 54.7
5 ft 5 in / 165 cm 61.5 57.0
5 ft 6 in / 168 cm 63.8 59.3
5 ft 7 in / 170 cm 66.1 61.6
5 ft 8 in / 173 cm 68.4 63.9
5 ft 9 in / 175 cm 70.7 66.2
5 ft 10 in / 178 cm 73.0 68.5
5 ft 11 in / 180 cm 75.3 70.8
6 ft 0 in / 183 cm 77.6 73.1
6 ft 1 in / 185 cm 79.9 75.4
6 ft 2 in / 188 cm 82.2 77.7
6 ft 3 in / 191 cm 84.5 80.0
6 ft 4 in / 193 cm 86.8 82.3
6 ft 5 in / 196 cm 89.1 84.6
6 ft 6 in / 198 cm 91.4 86.9
6 ft 7 in / 201 cm 93.7 89.2
6 ft 8 in / 203 cm 96.0 91.5
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 18 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
INDEX A
Acetylsalicylic acid (Aspirin) (ASA) [B01A; N02B]
Adrenalin + Lidocaine [N01B]
Albendazole [P02C]
Aluminium hydroxide + Magnesium hydroxide [A02A]
Alprazolam [N05B]
Amikacin [J01G]
Aminophylline [R03D]
Amitriptyline [N06A]
Amoxicillin [J01C]
Amoxicillin + Clavulanic acid (Co-amoxiclav) [J01C]
Ampicillin [J01C]
Ampicillin + Cloxacillin [J01C]
Amlodipine [C08]
Ascorbic Acid (Vit C) [A11G]
Atenolol [C07A]
Atorvastatin [C10A]
Azithromycin [J01F]
B Bacitracin [S01A]
Beclometasone dipropionate [R03]
Betamethasone [H02A]
Bisacodyl [A06]
Boric acid + glycerin [S02A]
C
Calcium Gluconate [A12A]
Calcium Phosphate + Vitamin D [A11C]
Captopril [C09A]
Carbamazepine [N03]
Cefixime [J01D]
Ceftriaxone [J01D
Celecoxib [M01A]
Chlorine [D08]
Chloramphenicol [J01B; S01A]
Chlorhexidine digluconate [D08A]
Chloroquine (base) [P01B]
Chlorphenamine maleate [R06A]
Chloroxylenol [D08A]
Ciprofloxacin [J01M]
Clarithromycin [J01F]
Clopidogrel [B01A]
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 19 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
Cloxacillin [J01C]
Colecalciferol (Vit D3) [A11C]
D Dexamethasone [H02A]
Diazepam [N05B]
Diclofenac [D11A; M01A]
Dimenhydrinate [R06A]
Diphenhydramine chloride [R06A]
Domperidone [A03F]
Doxycycline [J01A]
E
Erythromycin stearate [J01F]
Esomeprazole [A02B]
Ethanol 70% [D08]
F
Famotidine [A02B]
Ferrous sulfate (strength in Fe equivalent) + Folic acid [B03A]
Fenofibrate [C10]
Fluoxetine [NO6A]
Folic Acid (Vit B9) [A11H]
Furosemide [C03C]
G
Gatifloxacin [J01M]
Gentamicin [J01G;]
Glucose [B05C]
Glucose + Sodium chloride [B05B]
Glibenclamide [A10B]
H
Hydrochlorothiazide [C03A]
Hydrocortisone sodium succinate [H02A]
Hydrogen peroxide [D08]
Hydroxocobalamine (Vit B12) [B03B]
Hyoscine (butylbromide, hydrobromide) [A03B]
I
Ibuprofen [M01A]
Imipramine [NO6A]
Indomethacin [M01A]
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 20 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
K
Ketoprofen [M01A]
L
Levofloxacin [J01M]
Lidocaine [D04A]; N01B]
Loratadine [R06A]
M
Magnesium sulfate [N03A]
Mebendazole [P02C]
Mecobalamine (Vit B12) [B03B]
Meloxicam [M01A]
Metformin [A10B]
Methyldopa [C03A]
Methylprednisolone [H02A]
Metoclopramide [A03F]
Metronidazole [P01A]
Multivitamins and other minerals [A11A]
Multivitamins [A11B]
N
Nalidixic Acid [J01M] Naproxen [M01A]
Naphazoline [RO1]
Nifedipine [C08]
Nimesulide [M01A]
Nitrofurantoin [J01X]
Nystatin [A07A]
O
Ofloxacin [J01M]
Omeprazole [A02B]
Oral rehydration salts (ORS) [A07C]
Orphenadrine + Paracetamol [M03B]
P
Paracetamol (Acetaminophen) [N02B]
Penicillin Benzyl Benzathine [J01C]
Phenobarbital [N03A]
Piroxicam [M01A]
ن یمجدد معلول یایشفاخانه اح یرفورمول لست
Page 21 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ
Povidone iodine [D08A]
Prednisolone [H02A; S01B]
Promethazine [R06A]
Propranolol [C07A]
Pyridoxine (Vit B6) [A11H]
R
Ranitidine [A02B]
Retinol (Vit A) [A11C]
Ringer lactate [B05B]
S
Salbutamol [R03A; R03C]
Silver sulfadiazine [D06B]
Sodium chloride [B05B; R01A]
Sulfamethoxazole + Trimethoprim (Cotrimoxazole) [J01E]
T Tetracaine [S01H]
Tetracycline [S01A]
Tramadol [N02A]
Trihexyphenidyl [B02A]
V Valproic acid [N03]
W Water for Injection [V07A]